ReShape Lifesciences announced that Adam Smith, D.O., Bariatric Surgery Specialist and Chief Executive Officer of Ultimate Bariatrics in Dallas, Fort Worth, TX, and Christine Ren-Fielding, M.D., Professor of Surgery at NYU Grossman School of Medicine, Director of NYU Langone Health?s Weight Management Program and Chief of the Division of Bariatric Surgery, have successfully performed the first surgeries utilizing the company?s next generation, enhanced Lap-Band 2.0 FLEX.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1677 USD | -4.17% | -4.34% | -32.84% |
04-12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
04-01 | Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.84% | 4.1M | |
+8.88% | 219B | |
+8.68% | 185B | |
+14.25% | 135B | |
+28.18% | 107B | |
+14.65% | 51.28B | |
+4.48% | 51.01B | |
+4.39% | 41.85B | |
+7.00% | 37.02B | |
+26.06% | 31.27B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- Reshape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 Flex